Basis: Trailing twelve months (TTM net income over the latest quarterly balance sheet). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on assets (ROA) high or low?
The return on assets (ROA) of -99.89% is 151% below its 5-year average of -39.81%, near the low end of its 5-year range (-99.89%–-10.96%).
50.90% below its 12-month average of -66.19%.
Reported quarterly return on assets; no daily interpolation. Q1 FY2027 (2026-07-31): -35.66%.
RETURN ON ASSETS (ROA)
-99.89%
RETURN ON ASSETS (ROA) AVG TTM
-66.19%
RETURN ON ASSETS (ROA) AVG 3Y
-52.51%
RETURN ON ASSETS (ROA) AVG 5Y
-39.81%
RETURN ON ASSETS (ROA) AVG 10Y
-39.26%
RETURN ON ASSETS (ROA) AVG 15Y
-50.78%
RETURN ON ASSETS (ROA) AVG 20Y
-41.96%
CURRENT VS TTM AVG
-50.90%
CURRENT VS 3Y AVG
-90.22%
CURRENT VS 5Y AVG
-150.90%
CURRENT VS 10Y AVG
-154.42%
CURRENT VS 15Y AVG
-96.73%
CURRENT VS 20Y AVG
-138.04%
SECTOR MEDIAN · HEALTHCARE
-30.47%
median of 734 covered companies
CURRENT VS SECTOR MEDIAN
-227.83%
vs the sector median at left
MindWalk Holdings Corp.
Market Cap
$70.48M
Return on Assets (ROA)
-99.89%
TTM Avg
-66.19%
3Y Avg
-52.51%
5Y Avg
-39.81%
Market Cap
$68.60M
Return on Assets (ROA)
35.31%
TTM Avg
-14.11%
3Y Avg
-23.46%
5Y Avg
-20.68%
Market Cap
$72.94M
Return on Assets (ROA)
-130.37%
TTM Avg
-128.36%
3Y Avg
-112.34%
5Y Avg
-87.04%
Market Cap
$67.84M
Return on Assets (ROA)
-33.34%
TTM Avg
-56.30%
3Y Avg
-89.26%
5Y Avg
-70.59%
Market Cap
$67.38M
Return on Assets (ROA)
-3.41%
TTM Avg
5.09%
3Y Avg
-8.30%
5Y Avg
-5.06%
Market Cap
$66.30M
Return on Assets (ROA)
-107.09%
TTM Avg
-123.27%
3Y Avg
-270.15%
5Y Avg
-219.64%
Market Cap
$65.46M
Return on Assets (ROA)
-87.09%
TTM Avg
-130.17%
3Y Avg
-272.35%
5Y Avg
-217.34%
Market Cap
$75.84M
Return on Assets (ROA)
-55.32%
TTM Avg
-66.75%
3Y Avg
-58.76%
5Y Avg
-49.95%
Market Cap
$64.96M
Return on Assets (ROA)
-162.91%
TTM Avg
-58.42%
3Y Avg
-64.67%
5Y Avg
-61.98%
| NAME | MARKET CAP | RETURN ON ASSETS (ROA) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| MindWalk Holdings Corp. (HYFT) | $70.48M | -99.89% | -66.19% | -52.51% | -39.81% |
| Fortress Biotech, Inc. (FBIO)vs › | $68.60M | 35.31% | -14.11% | -23.46% | -20.68% |
| Gain Therapeutics, Inc. (GANX)vs › | $72.94M | -130.37% | -128.36% | -112.34% | -87.04% |
| iBio, Inc. (IBIO)vs › | $67.84M | -33.34% | -56.30% | -89.26% | -70.59% |
| Champions Oncology, Inc. (CSBR)vs › | $67.38M | -3.41% | 5.09% | -8.30% | -5.06% |
| RenovoRx, Inc. (RNXT)vs › | $66.30M | -107.09% | -123.27% | -270.15% | -219.64% |
| Cingulate Inc. (CING)vs › | $65.46M | -87.09% | -130.17% | -272.35% | -217.34% |
| Hyperfine, Inc. (HYPR)vs › | $75.84M | -55.32% | -66.75% | -58.76% | -49.95% |
| Gossamer Bio, Inc. (GOSS)vs › | $64.96M | -162.91% | -58.42% | -64.67% | -61.98% |
| Outset Medical, Inc. (OM)vs › | $76.10M | -30.65% | -38.63% | -43.27% | -38.60% |
ROA
-99.9%
ROE
-250.4%
ROA = Net Income / Total Assets
Return on assets measures how efficiently a company generates profit from its total assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON ASSETS (ROA) |
|---|---|
| 2026-04-30 | -64.36% |
| 2025-04-30 | -68.03% |
| 2024-04-30 | -43.53% |
| 2023-04-30 | -34.13% |
| 2022-04-30 | -17.87% |
| 2021-04-30 | -10.96% |
| 2020-04-30 | -19.00% |
| 2019-04-30 | -26.87% |
| 2018-04-30 | -21.04% |
| 2017-04-30 | -137.03% |
| 2016-04-30 | 10.94% |
| 2014-12-31 | -135.44% |
| 2013-12-31 | 47.78% |
| 2012-12-31 | -191.32% |
| 2011-12-31 | -303.73% |
| 2010-12-31 | -2433.72% |
| 2009-12-31 | -16.69% |
| 2008-12-31 | -6.90% |
| 2007-12-31 | -13.43% |
| 2006-12-31 | -7.47% |
| 2005-12-31 | -10.26% |
| 2004-12-31 | -4.37% |
| 2003-12-31 | -39.11% |
| 2002-12-31 | -30.60% |
| 2001-12-31 | -26.77% |
| 2000-12-31 | -11.59% |
| 1999-12-31 | -306.18% |
| 1998-12-31 | -75.53% |
| 1997-12-31 | -26.07% |
| 1996-12-31 | -18.58% |
